EMIS Group plc Preliminary Results for 2010

EMIS Group plcEMIS Group plc, the UK's leading supplier of clinical software and related services to GPs and other healthcare practitioners, announced its results for the year ended 31 December 2010.

Total Group revenue was £62.4m, an increase of £4.7m over 2009.

Core business recurring revenue, which excludes Canada, increased by £8.1m (19%) to £50.8m (2009: £42.7m). This includes hosting to Connecting for Health standards, which commenced at the end of December 2009 and generated revenues of £4.5m in 2010.

The increased core recurring revenue was partly offset by a reduction in PCT spending on hardware and other services being generally lower margin revenue streams. As a result, recurring revenue was 82% of core revenue, up from 74% for 2009.

UK GP software market leading position:

  • growth in UK market share to 53.8% (2009: 52.5%)
  • 5,576 EMIS GP practices at year end (2009: 5,377 EMIS GP practices)
  • market share in Scotland increased from 12.7% to 51.5% by year end

EMIS Web accredited in September 2010 and controlled roll-out commenced
By the year end:

  • 44 GP practices installed
  • 433 orders placed
  • 1,665 orders for the EMIS Web familiarisation service

RX Systems:

  • alignment on track
  • high street pharmacy market share increased from 20.5% to 25%

Strategic review of Canadian operation concluded and managed exit underway
Transformation of healthcare delivery in the UK opening up new markets for EMIS Web:

  • in January 2011 EMIS won a five year contract, with an initial value of £1.8 million, to deliver a shared patient healthcare record for primary healthcare teams across Cheshire
  • EMIS continues to pilot EMIS Web across a variety of healthcare sectors in Liverpool, London and Cumbria
EMIS chosen to provide electronic healthcare records for the Australian Department of Defence under a five year contract

Sean Riddell, Chief Executive of EMIS Group, said: "2010 was a busy year for EMIS Group. In our core business we have achieved accreditation and started the controlled roll-out of EMIS Web, our transformational next generation healthcare IT system. Working with GPs and commissioning groups to fulfil the objectives described in the NHS White Paper, we are already seeing a high level of intent to upgrade. Of the first wave of 52 GP consortia announced, representing 22% of England's GP practices, 77% are already EMIS users. These pathfinder organisations will shape the way that GP consortia operate in the future.

"We made the strategic acquisition of RX Systems, significantly increased our market share in Scotland, formed a joint venture to deliver wider interoperability through Healthcare Gateway, progressed existing and new extended primary care and community projects in Liverpool, London, Cumbria and Cheshire and extended our international reach into Australia.

"We remain focussed on cross-organisational healthcare and are confident that we can help healthcare professionals to deliver clinical benefit and improved efficiency through our software and services."

Related news articles:

About EMIS
EMIS Group* is the UK's leading supplier of software and related services to GP practices. As at 19 January 2011 53.7% of GPs in the UK use an EMIS system.

EMIS' core activities include software licensing and support, hardware support and maintenance services, hardware sales, third party software sales and training services.

Static and mobile EMIS clinical applications are extensively used throughout the globe, including UK Ministry of Defence establishments in Belize, Brunei, Cyprus, Falkland Islands, Gibraltar, Italy and Nepal. Other non-military international installations include: Jamestown Hospital, St Helena; King Edward VII Memorial Hospital, Falkland Islands; Emirates Airline Clinic, which uses EMIS software at two staff clinics in Dubai.

Established in 1987, EMIS' shares were listed on AIM under the trading symbol EMIS.L following a successful fundraising in March 2010.

www.emis-online.com

* EMIS Group is a trading name of EMIS Group plc. Registered In England. No 6553923. Registered Office: Fulford Grange, Micklefield Lane, Rawdon, Leeds, LS19 6BA.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...